Stroke Motor Rehabilitation and Recovery Study (SMaHRT)

Mass General Brigham

Status: Enrolling

Conditions: Stroke, Ischemic

Study type: Observational

Funder types: Other

Identifiers

NCT03485040

2017P000868

Details and patient eligibility

About

SMaHRT (Stroke Motor reHabiliation and Recovery sTudy) is a longitudinal study aimed at understanding the natural history of upper extremity motor recovery after ischemic and hemorrhagic stroke.

Full description

Participants will be enrolled in the SMaHRT study during their acute stroke hospitalization and will have research visits spanning the post-stroke care continuum at approximately 6 weeks, 3 months, 6 months, one year, two years, and three years after stroke. The study will collect demographics and clinical outcome measures, clinical neuroimages, video and robot-kinematic data and neurophysiology data through TMS and EEG in order to quantify the course of motor recovery. The research visits may be accompanied by a comprehensive clinical visit to the Massachusetts General Hospital Neurorecovery Clinic. The goal is to understand the behavioral, neuroanatomic, and neurophysiologic underpinnings of motor recovery toward developing personalized strategies and neurotechnologies to facilitate neurorehabilitation and enable better recovery for people with stroke.

Enrollment: 300 estimated patients

Sex: All

Ages: 18 to 90 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria

• Age 18 - 90
• Upper extremity motor weakness after ischemic and/or hemorrhagic stroke as defined by a score of >=1 on NIH Stroke Scale Arm Motor Drift Questions 5A or 5B
• Ability to follow simple commands in English
• Score of zero or 1 on the NIH Stroke Scale Level of Consciousness Questions 1a and 1b and a score of zero on the NIH Stroke Scale Level of Consciousness Question 1c.
• Stable medical status as determined by primary care team
• Inpatient on the MGH stroke neurology service

Exclusion Criteria

• Prior history of developmental, neurologic, or major psychiatric disorder resulting in functional disability
• Prior history of visual or auditory disorders limiting ability to participate in testing
• Evidence of an uncontrolled seizure disorder
• Patients for whom EEG leads are contraindicated